Horst Bierau
Horst Bierau publishes mostly in Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology, on topics such as Monoclonal and Polyclonal Antibodies Research, Protein purification and stability and Glycosylation and Glycoproteins Research.
- World rank
- #4,072,165 of 7,710,434 ranked researchers
- Rank in Italy
- #138,020 of 242,206
- Works
- 19
- Citations
- 482
- Citations per work
- 25.4
What does Horst Bierau research?
Horst Bierau's work is mostly in Biochemistry, Genetics and Molecular Biology (40%), Medicine (21%), Immunology and Microbiology (16%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences1156.1%
- Health Sciences421.0%
- Medicine421.0%
- Everything else317.6%
- Physical Sciences15.3%
- Engineering15.3%
- 1Molecular Biology33% of their works
- 2Radiology, Nuclear Medicine and Imaging18% of their works
- 3Immunology16% of their works
- 4Biotechnology7% of their works
- 5Biomedical Engineering5% of their works
- 6Oncology4% of their works
Research topics
- Monoclonal and Polyclonal Antibodies Research
- Protein purification and stability
- Glycosylation and Glycoproteins Research
- Viral Infectious Diseases and Gene Expression in Insects
- interferon and immune responses
- Enzyme Production and Characterization
- Transgenic Plants and Applications
- Galectins and Cancer Biology
Which keywords describe Horst Bierau's research?
The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Biopharmaceuticals, Fc Receptors, Recombinant Proteins and Protein Aggregation.
- Vaccine Antigens
- Microbial Enzymes
- Galectins
- Viral Infection
- Mammalian Cells
- Immune System
- Cancer
- Protein Aggregation
- Fc Receptors
- Antibody Engineering
- Monoclonal Antibodies
- Glycosylation
- Therapeutic Antibodies
- Biopharmaceuticals
- Recombinant Proteins
- Stability
- Glycans
- Innate Immunity
- Recombinant Protein
- Biotechnological Applications
- Immune Regulation
- Plant Molecular Farming
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Glycosylation183 topics
- Monoclonal Antibodies182 topics
- Therapeutic Antibodies182 topics
- Antibody Engineering101 topic
- Biopharmaceuticals102 topics
- Fc Receptors101 topic
- Recombinant Proteins102 topics
- Protein Aggregation81 topic
- Stability81 topic
- Cancer72 topics
- Glycans51 topic
- Immune System51 topic
- Innate Immunity31 topic
- Mammalian Cells31 topic
- Recombinant Protein31 topic
- Viral Infection31 topic
- Biotechnological Applications21 topic
- Galectins21 topic
- Immune Regulation21 topic
- Microbial Enzymes21 topic
- Plant Molecular Farming21 topic
- Vaccine Antigens21 topic
Where does Horst Bierau work?
Horst Bierau's main affiliation in the publication record is Merck Serono S.p.A. (Italy), Italy.
How many publications and citations does Horst Bierau have?
OpenAlex counts 19 works and 482 citations for Horst Bierau, an h-index of 12, ranking #4,072,165 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Horst Bierau. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.